The reported statements, read against the company's own industry.
Financials view
Market Capitalization
440.44MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Revenue (TTM)
48.55MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Profit Margin
-225.34%
vs Medical Devices peers
Updated Oct 28, 2026
Beta
1.03x
vs all stocks
Updated Oct 28, 2026
52-Week Change
23.03%
vs all stocks
Updated Oct 28, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 28, 2026
Market Capitalization
440.44MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Enterprise Value
360.60MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Forward P/E
-4.26x
vs Medical Devices peers
Updated Oct 28, 2026
Price to Sales (TTM)
9.07x
vs Medical Devices peers
Updated Oct 28, 2026
Price to Book (MRQ)
4.88x
vs Medical Devices peers
Updated Oct 28, 2026
Enterprise to Revenue
7.43x
vs Medical Devices peers
Updated Oct 28, 2026
Enterprise to EBITDA
-3.39x
vs Medical Devices peers
Updated Oct 28, 2026
Gross Margin
59.10%
vs Medical Devices peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 54.87%.Updated Oct 28, 2026
Profit Margin
-225.34%
vs Medical Devices peers
Updated Oct 28, 2026
Operating Margin
-248.48%
vs Medical Devices peers
Updated Oct 28, 2026
Return on Assets (TTM)
-41.41%
vs Medical Devices peers
Updated Oct 28, 2026
Return on Equity (TTM)
-118.24%
vs Medical Devices peers
Updated Oct 28, 2026
Revenue (TTM)
48.55MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Revenue per Share (TTM)
1.00USDUpdated Oct 28, 2026
Quarterly Revenue Growth
117.80%
vs Medical Devices peers
Updated Oct 28, 2026
Gross Profit (TTM)
26.64MUSD
vs all stocks (USD)
Updated Oct 28, 2026
EBITDA (TTM)
-106.51MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Net Income (TTM)
-109.39MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Operating Cash Flow (TTM)
-95.94MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Levered Free Cash Flow (TTM)
-59.24MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 28, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Oct 28, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 28, 2026
Payout Ratio
0.00%
vs Medical Devices peers
Updated Oct 28, 2026
Revenue
35.26MUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
19.49MUSDFY2025 · Dec 31, 2025
Gross Profit
15.76MUSDFY2025 · Dec 31, 2025
Operating Income
-68.34MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-69.11MUSDFY2025 · Dec 31, 2025
Net Income
-69.11MUSDFY2025 · Dec 31, 2025
EBIT
-64.16MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-62.65MUSDFY2025 · Dec 31, 2025
Research & Development
31.59MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
52.51MUSDFY2025 · Dec 31, 2025
Non-operating Interest Income
4.20MUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
4.95MUSDFY2025 · Dec 31, 2025
EPS (Basic)
-1.66USDFY2025 · Dec 31, 2025
EPS (Diluted)
-1.66USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
41.73MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
41.73MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-69.11MUSDFY2025 · Dec 31, 2025
Operating Cash Flow
-64.58MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
40.55MUSDFY2025 · Dec 31, 2025
Interest Paid
4.05MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-69.11MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
1.51MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
10.15MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
2.32MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-6.76MUSDFY2025 · Dec 31, 2025
Change in Accounts Payable (CF)
1.22MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-3.91MUSDFY2025 · Dec 31, 2025
Purchase of Investments
-100.69MUSDFY2025 · Dec 31, 2025
Sale of Investments
48.39MUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-52.31MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025
Long-term Debt Payments
-20.40MUSDFY2025 · Dec 31, 2025
Other Financing Charges
-2.15MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
78.05MUSDFY2025 · Dec 31, 2025
Shares Outstanding
52.86MSharesUpdated Oct 28, 2026
Float Shares
43.67MSharesUpdated Oct 28, 2026
Shares Short
5.37MSharesUpdated Oct 28, 2026
Short Ratio
7.46days
vs all stocks
Updated Oct 28, 2026
Short % of Shares Outstanding
10.43%
vs all stocks
Updated Oct 28, 2026
% Held by Insiders
9.87%
vs all stocks
Updated Oct 28, 2026
% Held by Institutions
39.64%
vs all stocks
Updated Oct 28, 2026
Total Cash (MRQ)
142.66MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Total Cash per Share (MRQ)
2.70USDUpdated Oct 28, 2026
Total Debt (MRQ)
62.82MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Total Debt to Equity (MRQ)
0.6956x
vs Medical Devices peers
Updated Oct 28, 2026
Current Ratio (MRQ)
6.75x
vs Medical Devices peers
Updated Oct 28, 2026
Book Value per Share (MRQ)
1.71USDUpdated Oct 28, 2026
Total Assets
126.27MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
117.53MUSDFY2025 · Dec 31, 2025
Total Liabilities
65.22MUSDFY2025 · Dec 31, 2025
Total Non-current Assets
8.74MUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
40.88MUSDFY2025 · Dec 31, 2025
Total Current Liabilities
24.35MUSDFY2025 · Dec 31, 2025
Cash
6.61MUSDFY2025 · Dec 31, 2025
Cash Equivalents
33.62MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
40.23MUSDFY2025 · Dec 31, 2025
Other Short-term Investments
53.80MUSDFY2025 · Dec 31, 2025
Accounts Receivable
12.12MUSDFY2025 · Dec 31, 2025
Inventory
6.70MUSDFY2025 · Dec 31, 2025
Accounts Payable
4.06MUSDFY2025 · Dec 31, 2025
Short-term Debt
496.00KUSDFY2025 · Dec 31, 2025
Other Current Liabilities
532.00KUSDFY2025 · Dec 31, 2025
Long-term Debt
40.88MUSDFY2025 · Dec 31, 2025
Common Stock (Book)
41.00KUSDFY2025 · Dec 31, 2025
Retained Earnings
-1.02BUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
61.05MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
4.79USDUpdated Oct 28, 2026
52-Week High
10.64USDUpdated Oct 28, 2026
52-Week Change
23.03%
vs all stocks
Updated Oct 28, 2026
Beta
1.03x
vs all stocks
Updated Oct 28, 2026
50-Day MA
9.14USDUpdated Oct 28, 2026
200-Day MA
7.16USDUpdated Oct 28, 2026
Avg 10-Day Volume
565.54KSharesUpdated Oct 28, 2026
Avg 30-Day Volume
686.17KSharesUpdated Oct 28, 2026
Diluted EPS (TTM)
-2.23USDUpdated Oct 28, 2026
Other Income / Expense
-23.00KUSDFY2025 · Dec 31, 2025
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is -248.5%, lower than 95% of its Medical Devices peers (median 7.8%)Significant